Loading clinical trials...
Loading clinical trials...
A Phase 2 Drug-Vaccine Interaction Study to Examine Whether Co-administering AV7909 With Ciprofloxacin or Doxycycline Affects Antibiotic Pharmacokinetics or AV7909 Immunogenicity in Healthy Adults
Conditions
Interventions
Ciprofloxacin 500Mg Tablet
Doxycycline 100Mg Tablet
+1 more
Locations
4
United States
Avail Clinical Research, LLC
DeLand, Florida, United States
The Center for Pharmaceutical Research
Kansas City, Missouri, United States
Meridian Clinical Research, LLC
Omaha, Nebraska, United States
New Orleans Center for Clinical Research / Volunteer Research Group
Knoxville, Tennessee, United States
Start Date
August 12, 2019
Primary Completion Date
March 5, 2020
Completion Date
March 19, 2020
Last Updated
September 8, 2025
NCT00050310
NCT05997264
NCT03569514
NCT07268612
NCT04660201
NCT05672875
Lead Sponsor
Emergent BioSolutions
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions